General Announcement:: GPL to partner with Novartis to promote,commercialize,distribute 3 respiratory products in Brazil

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Jun-2019 11:30:29
Status
New
Announcement Sub Title
GPL to partner with Novartis to promote,commercialize,distribute 3 respiratory products in Brazil
Announcement Reference
SG190624OTHR4V9M
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
24/06/2019 09:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark to partner with Novartis to promote, commercialize and distribute three respiratory products in Brazil

Attachments

PR_SGX_24062019.pdf
Total size =3360K